Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
about
Combined effects of aerobic exercise and diet on lipids and lipoproteins in overweight and obese adults: a meta-analysisOpening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular riskThe relationship between Lp(a) and CVD outcomes: a systematic reviewEffects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesOmega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemiaNonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB CouncilQuantifying your body: a how-to guide from a systems biology perspectiveInvestigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy.Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic targetGrowth environment and sex differences in lipids, body shape and diabetes risk.Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis.A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study.Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular eventsUsing apolipoprotein B to manage dyslipidemic patients: time for a change?Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama StudyEfficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials.Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trialsPrediction of risk factors for coronary heart disease using Framingham Risk Score in Korean men.Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE studyNon-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.Association between non-high-density-lipoprotein-cholesterol levels and the prevalence of asymptomatic intracranial arterial stenosis.Apolipoprotein B is highly associated with the risk of coronary heart disease as estimated by the Framingham risk score in healthy Korean men.Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetesNon-high-density lipoprotein cholesterol on the risks of stroke: a result from the Kailuan study.Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patientsUse of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.The regulation of alfalfa saponin extract on key genes involved in hepatic cholesterol metabolism in hyperlipidemic ratsClinical applications of advanced lipoprotein testing in diabetes mellitusAssociation of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort studyThe role of triglycerides in atherosclerosis.Particulate matter exposures, mortality, and cardiovascular disease in the health professionals follow-up study.Lipid levels and the risk of ischemic stroke in women.Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and womenEffects of alfalfa saponin extract on mRNA expression of Ldlr, LXRα, and FXR in BRL cells.Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins
P2860
Q21285127-5C7C21E7-2A65-48BF-A46F-5F72B9BEE150Q24626884-9C44F838-5D38-4819-AEE8-8F082E6FAD1CQ26749317-88431F60-2B35-43B9-AE31-A2281E32A0CBQ26827245-4806470D-9977-4501-90C7-9F98CB37B133Q26853571-87571AF2-94D8-4562-8041-F6A6AC48C452Q28076399-3876656D-8809-460A-802A-ED1968B1675FQ28084156-65B4E16C-9A82-4140-A59E-832195DA528AQ28272991-841FE271-E27D-407F-99AC-64DDED330370Q30245541-30EAB1F8-7083-4DE2-A8E7-DB7DB652D675Q30370672-BA97A626-D07A-42D6-B295-DD766A88A5A5Q33303679-0D48D6FA-6D94-4D83-B382-51983F3AB9BFQ33604888-326BFC07-C8FF-4C2E-9997-8B0FEF40EFA8Q33789171-44C82657-4F5D-474A-8D7D-6064ABA6CBA3Q33789885-20F7EB30-7055-466D-8015-62933BAF095BQ33812634-4AB93812-9CA9-464B-9A98-F5F0C07351F4Q33820011-C70D6B7F-96CA-4A1E-B9B1-6EB958B0F543Q33918753-D8722078-0ACF-4613-8737-C93CE093B90FQ33933632-1D5BF9FD-941F-4D0B-B571-4415C931B96EQ33972551-BEA04001-5B33-487C-8F27-B2E900A63134Q34042886-8414B7B6-E25D-40D1-A344-48E6B7288820Q34119914-A2F826BD-3658-4F1F-9818-9DD06937A6B1Q34297213-A024DE52-07F3-47CE-B8F8-56F96F6F467FQ34427908-9ADFBD6B-89C1-4A47-8D37-2B18B22E4C19Q34481529-506824C0-2D0F-4CEC-A57A-47CD56DC2C30Q34668335-130D05D8-5F05-4178-8576-988770A665F6Q34755882-D4AE10C2-C9AE-41A2-9999-B4B5341D1356Q34853434-934F1C52-4D67-4AAF-B851-19901577911BQ34992892-71143B88-B566-47DA-BA5A-384B37EDEDFDQ34994840-197EB7A5-54DE-4373-B829-D7B7B56FFD4CQ35005934-5302E951-F56F-40BC-82AB-CA776FC08043Q35007779-8D53CF30-FAD0-481C-8B4F-5B9C2A23EC8EQ35088651-6B8A8D98-CA00-40AF-B4D1-18A38E72324BQ35598303-BF092854-DEDC-471B-8EC2-379D640FA1DEQ35602017-D11D472B-2391-4B1E-AA13-BE561D8E3EC8Q35602424-BC3ED701-645C-4833-987A-829EADBF0E7FQ35611297-83F6C4D6-E205-4D1D-9B57-8312EE12AAB0Q35652626-2B1B5206-8871-448B-BC4C-8E71119A2707Q35684196-EA0920B4-19F6-4B30-AF18-34E378BCDDAEQ35753759-9F690BEB-333A-49F1-B31B-F9C254752190Q35785415-9B5A7779-EA0C-4308-AC4A-3A0D69B7DEE7
P2860
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Non-high-density lipoprotein c ...... coronary heart disease in men.
@en
Non-high-density lipoprotein c ...... coronary heart disease in men.
@nl
type
label
Non-high-density lipoprotein c ...... coronary heart disease in men.
@en
Non-high-density lipoprotein c ...... coronary heart disease in men.
@nl
prefLabel
Non-high-density lipoprotein c ...... coronary heart disease in men.
@en
Non-high-density lipoprotein c ...... coronary heart disease in men.
@nl
P50
P1433
P1476
Non-high-density lipoprotein c ...... coronary heart disease in men.
@en
P2093
Cynthia J Girman
Frank M Sacks
P304
P356
10.1161/CIRCULATIONAHA.104.532499
P407
P577
2005-11-01T00:00:00Z